Covista (CVSA) Change in Accured Expenses (2009 - 2026)

Covista (CVSA) has reported Change in Accured Expenses for 18 consecutive years, with $22.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 18.14% year-over-year to $22.0 million; the TTM figure through Mar 2026 stood at -$6.6 million (down 609.6% YoY), while the FY2025 annual figure was -$15.9 million, down 158.16% from the prior year.
• Change in Accured Expenses improved to $22.0 million in Q1 2026 per CVSA's latest filing, from $1.2 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $76.2 million in Q2 2022 and bottomed at -$65.9 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged $290823.5 across 5 years, with a median of -$4.0 million in 2023.
• On a YoY basis, Change in Accured Expenses climbed as much as 1622.94% in 2022 and fell as far as 467.44% in 2022.
• Covista's Change in Accured Expenses stood at $7.9 million in 2022, then surged by 43.91% to $11.4 million in 2023, then sank by 166.59% to -$7.6 million in 2024, then surged by 116.25% to $1.2 million in 2025, then soared by 1689.59% to $22.0 million in 2026.
• Business Quant data shows CVSA's Change in Accured Expenses at $22.0 million in Q1 2026, $1.2 million in Q4 2025, and -$24.4 million in Q3 2025.